Endothelium Activation during Severe Yellow Fever Triggers an Intense Cytokine-Mediated Inflammatory Response in the Liver Parenchyma

Yellow fever (YF) is a pansystemic disease caused by the yellow fever virus (YFV), the prototype species of the family Flaviviridae and genus Flavivirus, and has a highly complex host-pathogen relationship, in which endothelial dysfunction reflects viral disease tropism. In this study, the in situ endothelial response was evaluated. Liver tissue samples were collected from 21 YFV-positive patients who died due to the disease and five flavivirus-negative controls who died of other causes and whose hepatic parenchyma architecture was preserved. Immunohistochemical analysis of tissues in the hepatic parenchyma of YF cases showed significantly higher expression of E-selectin, P-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and very late antigen-4 in YFV-positive cases than in flavivirus-negative controls. These results indicate that endothelium activation aggravates the inflammatory response by inducing the expression of adhesion molecules that contribute to the rolling, recruitment, migration, and construction of the inflammatory process in the hepatic parenchyma in fatal YF cases.

[1]  M. Diamond,et al.  Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury , 2020, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Tesh,et al.  Experimental yellow fever virus infection in the squirrel monkey (Saimiri spp.) I: gross anatomical and histopathological findings in organs at necropsy , 2020, Memorias do Instituto Oswaldo Cruz.

[3]  T. Monath,et al.  Yellow fever. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  A. Barrett,et al.  Molecular Characterization of Hamster-Adapted Yellow Fever Virus. , 2019, Vector borne and zoonotic diseases.

[5]  P. F. Vasconcelos,et al.  Upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in renal tissue in severe dengue in humans: Effects on endothelial activation/dysfunction. , 2019, Revista da Sociedade Brasileira de Medicina Tropical.

[6]  S. F. Aguiar,et al.  Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016–2019 , 2019, Journal of Virology.

[7]  I. Campbell,et al.  Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages , 2012, Journal of Neuroinflammation.

[8]  Christina L Gardner,et al.  Yellow fever: a reemerging threat. , 2010, Clinics in laboratory medicine.

[9]  P. F. Vasconcelos,et al.  Hepatocyte lesions and cellular immune response in yellow fever infection. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  J. Quaresma,et al.  Revisiting the liver in human yellow fever : Virus-induced apoptosis in hepatocytes associated with TGF-β, TNF-α and NK cells activity , 2006 .

[11]  N. King,et al.  Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines , 1997, Journal of virology.

[12]  P. F. Vasconcelos,et al.  Midzonal lesions in yellow fever: a specific pattern of liver injury caused by direct virus action and in situ inflammatory response. , 2006, Medical hypotheses.

[13]  A. Prata Yellow fever. , 2000, Memorias do Instituto Oswaldo Cruz.